EIF5B
Eukaryotic translation initiation factor 5B
Also known as: DKFZp434I036, FLJ10524, IF2, IF2P_HUMAN, KIAA0741
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60841
- Gene
- EIF5B
- Ensembl
- ENSG00000158417
- Chromosome
- 2
- Canonical length
- 1220 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
Accurate initiation of translation in eukaryotes is complex and requires many factors, some of which are composed of multiple subunits. The process is simpler in prokaryotes which have only three initiation factors (IF1, IF2, IF3). Two of these factors are conserved in eukaryotes: the homolog of IF1 is eIF1A and the homolog of IF2 is eIF5B. This gene encodes eIF5B. Factors eIF1A and eIF5B interact on the ribosome along with other initiation factors and GTP to position the initiation methionine tRNA on the start codon of the mRNA so that translation initiates accurately. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1220 residues, UniProt reviewed canonical sequence.
>O60841|EIF5B
1 MGKKQKNKSE DSTKDDIDLD ALAAEIEGAG AAKEQEPQKS KGKKKKEKKK QDFDEDDILK
61 ELEELSLEAQ GIKADRETVA VKPTENNEEE FTSKDKKKKG QKGKKQSFDD NDSEELEDKD
121 SKSKKTAKPK VEMYSGSDDD DDFNKLPKKA KGKAQKSNKK WDGSEEDEDN SKKIKERSRI
181 NSSGESGDES DEFLQSRKGQ KKNQKNKPGP NIESGNEDDD ASFKIKTVAQ KKAEKKERER
241 KKRDEEKAKL RKLKEKEELE TGKKDQSKQK ESQRKFEEET VKSKVTVDTG VIPASEEKAE
301 TPTAAEDDNE GDKKKKDKKK KKGEKEEKEK EKKKGPSKAT VKAMQEALAK LKEEEERQKR
361 EEEERIKRLE ELEAKRKEEE RLEQEKRERK KQKEKERKER LKKEGKLLTK SQREARARAE
421 ATLKLLQAQG VEVPSKDSLP KKRPIYEDKK RKKIPQQLES KEVSESMELC AAVEVMEQGV
481 PEKEETPPPV EPEEEEDTED AGLDDWEAMA SDEETEKVEG NKVHIEVKEN PEEEEEEEEE
541 EEEDEESEEE EEEEGESEGS EGDEEDEKVS DEKDSGKTLD KKPSKEMSSD SEYDSDDDRT
601 KEERAYDKAK RRIEKRRLEH SKNVNTEKLR APIICVLGHV DTGKTKILDK LRHTHVQDGE
661 AGGITQQIGA TNVPLEAINE QTKMIKNFDR ENVRIPGMLI IDTPGHESFS NLRNRGSSLC
721 DIAILVVDIM HGLEPQTIES INLLKSKKCP FIVALNKIDR LYDWKKSPDS DVAATLKKQK
781 KNTKDEFEER AKAIIVEFAQ QGLNAALFYE NKDPRTFVSL VPTSAHTGDG MGSLIYLLVE
841 LTQTMLSKRL AHCEELRAQV MEVKALPGMG TTIDVILING RLKEGDTIIV PGVEGPIVTQ
901 IRGLLLPPPM KELRVKNQYE KHKEVEAAQG VKILGKDLEK TLAGLPLLVA YKEDEIPVLK
961 DELIHELKQT LNAIKLEEKG VYVQASTLGS LEALLEFLKT SEVPYAGINI GPVHKKDVMK
1021 ASVMLEHDPQ YAVILAFDVR IERDAQEMAD SLGVRIFSAE IIYHLFDAFT KYRQDYKKQK
1081 QEEFKHIAVF PCKIKILPQY IFNSRDPIVM GVTVEAGQVK QGTPMCVPSK NFVDIGIVTS
1141 IEINHKQVDV AKKGQEVCVK IEPIPGESPK MFGRHFEATD ILVSKISRQS IDALKDWFRD
1201 EMQKSDWQLI VELKKVFEIILocalizationUniProt · AlphaFold · HPA
Whether an antibody against EIF5B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 97 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 97 nTPM
- heart muscle: 84 nTPM
- choroid plexus: 80 nTPM
- spinal cord: 76 nTPM
- midbrain: 59 nTPM
- colon: 54 nTPM
Single-cell type
- early spermatids: 753 nCPM
- early primary spermatocytes: 751 nCPM
- late primary spermatocytes: 608 nCPM
- differentiating spermatogonia: 601 nCPM
- hepatocytes: 551 nCPM
- suprabasal keratinocytes: 412 nCPM
Immune cell
- plasmacytoid DC: 26 nTPM
- memory B-cell: 21 nTPM
- basophil: 20 nTPM
- naive B-cell: 20 nTPM
- NK-cell: 19 nTPM
- MAIT T-cell: 18 nTPM
Brain region
- hypothalamus: 41 nTPM
- medulla oblongata: 40 nTPM
- thalamus: 38 nTPM
- basal ganglia: 37 nTPM
- spinal cord: 37 nTPM
- white matter: 36 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.62
- DepMap mean gene effect
- -0.61
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- GTP binding
- GTPase activity
- metal ion binding
- RNA binding
- translation initiation factor activity
- tRNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Translational (tr)-type GTP-binding domain
- Small GTP-binding domain
- Translation protein, beta-barrel domain superfamily
- Translation initiation factor IF- 2
- Translation initiation factor IF- 2, domain 3
- P-loop containing nucleoside triphosphate hydrolase
- Translation initiation factor IF-2, domain 3 superfamily
- Elongation factor Tu GTP binding domain
- Translation-initiation factor 2
- Elongation factor Tu-type domain
- Elongation factor Tu domain 4
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EIF5B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EIF5B as an antibody target. Whether an autoantibody or antibody against EIF5B could matter depends on whether native EIF5B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EIF5B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EIF5B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...